Learn about coronary artery bypass grafting (CABG) surgery, a life-saving procedure for severe heart disease, offering ...

Plans for filing an IND was agreed with the FDA in a recent meeting –– Positive preclinical results of the small-diameter ATEV were recently ...

DUBLIN--(BUSINESS WIRE)--The "Coronary Artery Bypass Grafting (CABG) Devices Sector, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This study provides a detailed ...

Humacyte (HUMA) announced that it plans to file an Investigational New Drug, IND, application with the U.S. Food and Drug Administration, FDA, ...

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA), a biotechnology company valued at $567 million, has announced its intention to file an Investigational New Drug (IND) application with the U.S. Food and ...

Jacobo’s article is well worth reading as it describes a litany of ways major corporations game the system at the cost of lives and billions of dollars. Many of these “opportunities” arise from the ...

History was created this week when a team of specialists conducted Fiji’s first-ever quadruple graft heart bypass surgery at ...

John Sroufe alleges a surgical team at Research Medical Center used a disinfectant he was allergic to while preparing him for heart surgery, causing respiratory failure and anaphylactic shock.